Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products

**Background:** The prioritization of public funds in an equitable and ethically sound manner along with efficient budget allocation are key challenges for governments and budget holders. Following the introduction of generics/biosimilars, the potential total budget made available for reallocation r...

Full description

Saved in:
Bibliographic Details
Main Authors: Samira Toghanian, John Moshtaghi-Svensson, Maria Papageorgiou, Kristin Kittelsen, Christiaan Dolk, Markus Hultstrand, Stina Salomonsson
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2022-02-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/jheor.2022.29624
Tags: Add Tag
No Tags, Be the first to tag this record!